Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2023 Earnings Conference Call February 21, 2024 4:30 PM ET
Company Participants
Susan Morrison - Executive Vice President and Chief Administrative Officer
John Sheridan - President and Chief Executive Officer
Leigh Vosseller - Executive Vice President and Chief Financial Officer
Conference Call Participants
Steve Lichtman - Oppenheimer & Company
Matt Miksic - Barclays
Brooks O’Neil - Lake Street Capital Markets
Chris Pasquale - Nephron Research
Travis Steed - Bank of America
Mike Kratky - Leerink Partners
Matt Taylor - Jefferies
Danielle Antalffy - UBS
Jayson Bedford - Raymond James
Jeff Johnson - Baird
Alex Nowak - Craig-Hallum
Joshua Jennings - TD Cowen
Operator
Thank you for standing by, and welcome to Tandem Diabetes Care’s Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to EVP and Chief Administrative Officer, Susan Morrison. Please go ahead.
Susan Morrison
Hello, everyone and thanks for joining Tandem’s 2023 fourth quarter and year end earnings call. As a reminder, today’s discussion will include forward-looking statements. These statements reflect management’s expectations about future events, product development time lines and financial performance and operating plans and speak only as of today’s date. There are risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward-looking statements. A list of factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is highlighted in our press release issued earlier today and under the Risk Factors portion and elsewhere in our most recent annual report on Form 10-K, quarterly report on Form 10-Q and in our other SEC filings. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or other factors.
Today’s discussion will also include references to a number of GAAP and non-GAAP financial measures. Non-GAAP financial measures are provided to give our investors information that we believe is indicative of our core operating performance and reflects our ongoing business operations. We believe these non-GAAP financial measures facilitate better comparisons of operating results across reporting periods. Any non-GAAP information presented should not be considered as a substitution independently or superior to results prepared in accordance with GAAP. Please refer to our earnings release, quarterly report on Form 10-K and the Investor Center portion of our website for a reconciliation of these measures to their most directly comparable GAAP financial measure.